Paper30054833
Artificial intelligence in drug design.
Zhong F and 15 others. Sci China Life Sci, 2018. Cited by 122 papers, by iCite.
Cite this record
ConductScience Library. Artificial intelligence in drug design. Papers, record 30054833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30054833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artificial Intelligence | Major topic |
| Computer-Aided Design | Major topic |
| Drug Design | Major topic |
| Drug Discovery | Major topic |
| Computational Biology | |
| Computer Simulation | |
| Humans | |
| Pharmaceutical Preparations | |
| Pharmacokinetics | |
| Structure-Activity Relationship |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 122 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42640361 | AI-driven drug design: a comprehensive review. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42640361 | PubMed |
| 42558989 | Perspectives on the use and implementation of artificial intelligence in pharmacy education and training: Views of faculty, PharmD students, and pharmacists in Saudi Arabia. | Digit Health | 2026 | https://conductscience.org/library/papers/42558989 | PubMed |
| 42380674 | Integrating evolutionary and compositional features with ML and DL for robust and interpretable druggable protein prediction. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42380674 | PubMed |
| 42353251 | Ensemble Machine Learning- and Deep Learning-Driven Identification and Validation of Sennidin B as a Novel Dipeptidyl Peptidase-4 Inhibitor. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353251 | PubMed |
| 42342845 | Image-guided activation of drugs with electromagnetic radiation. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/42342845 | PubMed |
| 42277134 | Integrated in silico and in vitro assessment of Azadirachta indica leaf extract against multi-drug resistant Citrobacter koseri and Staphylococcus saprophyticus. | Sci Rep | 2026 | https://conductscience.org/library/papers/42277134 | PubMed |
| 42023085 | Application of deep learning-clinical baseline feature fusion model to predict postoperative mortality in elderly patients with hip fracture: a multicenter study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42023085 | PubMed |
| 41963934 | Application of artificial intelligence in lung cancer diagnosis, therapy, and prognosis. | BMC Med Genomics | 2026 | https://conductscience.org/library/papers/41963934 | PubMed |
| 41915327 | ADMETPred: a high-throughput ADMET prediction platform integrating multi-model algorithms and interpretable substructure identification. | Sci China Life Sci | 2026 | https://conductscience.org/library/papers/41915327 | PubMed |
| 41669468 | Histopathologic basis of a deep learning pelvic computed tomography model for prognostic prediction among patients with advanced high-grade serous ovarian carcinoma. | Quant Imaging Med Surg | 2026 | https://conductscience.org/library/papers/41669468 | PubMed |
| 41594562 | Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024). | Biomolecules | 2025 | https://conductscience.org/library/papers/41594562 | PubMed |
| 41593209 | AI and experimental convergence: a synergistic pathway to JAK2 inhibitor discovery. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/41593209 | PubMed |
| 41511497 | Unveiling the Influence of Polyphenols on Mitogen-activated Protein Kinases in Cancer. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41511497 | PubMed |
| 41321627 | Identifying CTSF and GSTM3 as chemoresistance therapeutic targets in breast cancer through multi-omics MR analysis. | iScience | 2025 | https://conductscience.org/library/papers/41321627 | PubMed |
| 41132837 | New insights into translational research in Alzheimer's disease guided by artificial intelligence, computational and systems biology. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41132837 | PubMed |
| 41088988 | Synthesis, Cytotoxicity Evaluation, and Molecular Dynamics of 4-Thiazolidinone Derivatives: A Potential Path to EGFR-Targeted Anticancer Therapy. | Curr Med Chem | 2026 | https://conductscience.org/library/papers/41088988 | PubMed |
| 40598326 | Artificial intelligence in dentistry: insights and expectations from Swiss dental professionals. | BMC Med Inform Decis Mak | 2025 | https://conductscience.org/library/papers/40598326 | PubMed |
| 40528990 | Role of artificial intelligence in revolutionizing drug discovery. | Fundam Res | 2025 | https://conductscience.org/library/papers/40528990 | PubMed |
| 40528034 | Advancing active compound discovery for novel drug targets: insights from AI-driven approaches. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40528034 | PubMed |
| 40370247 | The Evolution of Machine Learning in Medicinal Chemistry: A Comprehensive Bibliometric Analysis. | Curr Neuropharmacol | 2026 | https://conductscience.org/library/papers/40370247 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30054833
GET https://conductscience.org/api/papers/v1/30054833/cited_by?page=2